The American Society of Clinical Oncology-College of American Pathologists Guideline Update for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer

被引：7
|
作者：
Schnitt, Stuart J. [1 ,2 ,6 ]
Tarantino, Paolo [3 ,4 ]
Collins, Laura C. [2 ,5 ]
机构：
[1] Brigham & Womens Hosp, Dept Pathol, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Harvard Med Sch, Dana Farber Canc Inst, Breast Oncol Program, Boston, MA USA
[4] Univ Milan, Dept Oncol & Hemato Oncol, Milan, Italy
[5] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA USA
[6] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA
来源：
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE | 2023年 / 147卷 / 09期
关键词：
RECOMMENDATIONS;
D O I：
10.5858/arpa.2023-0187-ED
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
[No abstract available]
引用
收藏
页码：991 / 992
页数：2
相关论文
共 50 条
  • [21] Implementation of the 2018 Human Epidermal Growth Factor Receptor 2 Guideline by American Society of Clinical Oncology/College of American Pathologists Will Reduce False-Positive Tests
    Martin, Vittoria
    Valera, Alexandra
    De Joffrey, Melissa
    Banfi, Sara
    Mazzucchelli, Luca
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2019, 143 (04) : 411 - 412
  • [22] Impact of American Society of Clinical Oncology/College of American Pathologists guideline recommendations on HER2 testing in breast cancer
    Shah, Sejal S.
    Ketterling, Rhett P.
    Perez, Edith A.
    Chen, Beiyun
    VIRCHOWS ARCHIV, 2008, 452 : S23 - S24
  • [23] Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma
    Murray, Ciara
    Flanagan, Louise
    D'Arcy, Claire
    Gullo, Giuseppe
    Quinn, Cecily M.
    VIRCHOWS ARCHIV, 2020, 476 (03) : 367 - 372
  • [24] Assessing the impact of the 2018 American Society of Clinical Oncology/College of American Pathologists recommendations on human epidermal growth factor receptor 2 testing by fluorescence in situ hybridization in breast carcinoma
    Ciara Murray
    Louise Flanagan
    Claire D’Arcy
    Giuseppe Gullo
    Cecily M. Quinn
    Virchows Archiv, 2020, 476 : 367 - 372
  • [25] The updated 2018 American Society of Clinical Oncology/College of American Pathologists guideline on human epidermal growth factor receptor 2 interpretation in breast cancer: comparison with previous guidelines and clinical significance of the proposed in situ hybridization groups
    Woo, Ji Won
    Lee, Kyoungyul
    Chung, Yul Ri
    Jang, Min Hye
    Ahn, Soomin
    Park, So Yeon
    HUMAN PATHOLOGY, 2020, 98 : 10 - 21
  • [26] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    Wolff, Antonio C.
    Mangu, Pamela B.
    Temin, Sarah
    JOURNAL OF ONCOLOGY PRACTICE, 2010, 6 (04) : 195 - 197
  • [27] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    Dowsett, Mitch
    Allred, D. Craig
    Hagerty, Karen L.
    Badve, Sunil
    Fitzgibbons, Patrick L.
    Francis, Glenn
    Goldstein, Neil S.
    Hayes, Malcolm
    Hicks, David G.
    Lester, Susan
    Love, Richard
    Mangu, Pamela B.
    McShane, Lisa
    Miller, Keith
    Osborne, C. Kent
    Paik, Soonmyung
    Perlmutter, Jane
    Rhodes, Anthony
    Sasano, Hironobu
    Schwartz, Jared N.
    Sweep, Fred C. G.
    Taube, Sheila
    Torlakovic, Emina Emilia
    Valenstein, Paul
    Viale, Giuseppe
    Visscher, Daniel
    Wheeler, Thomas
    Williams, R. Bruce
    Wittliff, James L.
    Wolff, Antonio C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2784 - 2795
  • [28] American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
    Hammond, M. Elizabeth H.
    Hayes, Daniel F.
    Dowsett, Mitch
    Allred, D. Craig
    Hagerty, Karen L.
    Badve, Sunil
    Fitzgibbons, Patrick L.
    Francis, Glenn
    Goldstein, Neil S.
    Hayes, Malcolm
    Hicks, David G.
    Lester, Susan
    Love, Richard
    Mangu, Pamela B.
    McShane, Lisa
    Miller, Keith
    Osborne, C. Kent
    Paik, Soonmyung
    Perlmutter, Jane
    Rhodes, Anthony
    Sasano, Hironobu
    Schwartz, Jared N.
    Sweep, Fred C. G.
    Taube, Sheila
    Torlakovic, Emina Emilia
    Valenstein, Paul
    Viale, Giuseppe
    Visscher, Daniel
    Wheeler, Thomas
    Williams, R. Bruce
    Wittliff, James L.
    Wolff, Antonio C.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2010, 134 (06) : 907 - 922
  • [29] National Guidelines and Level of Evidence: Comments on Some of the New Recommendations in the American Society of Clinical Oncology and the College of American Pathologists Human Epidermal Growth Factor Receptor 2 Guidelines for Breast Cancer
    Rakha, Emad A.
    Pigera, Marian
    Shaaban, Abeer
    Shin, Sandra J.
    D'Alfonso, Timothy
    Ellis, Ian O.
    Lee, Andrew H. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (11)
  • [30] American Society of Clinical Oncology/College of American Pathologists 2018 Focused Update of Breast Cancer HER2 FISH Testing Guidelines
    Lin, Leo
    Sirohi, Deepika
    Coleman, Joshua F.
    Gulbahce, H. Evin
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 (04) : 479 - 485
12345